Literature DB >> 31255606

A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF.

Tingting Sha1, Xiaojuan Wang2, Wenwei Cheng3, Yan Yan4.   

Abstract

This meta-analysis aimed to study whether pregnancy-related outcomes and complications differed between patients with polycystic ovary syndrome (PCOS) and those with other causes of infertility who had undergone IVF. A systematic search of PubMed, Embase, the Cochrane Library and Chinese databases was carried out to identify relevant studies published before July 2018. Outcomes were expressed as odds ratios (OR) and 95% confidence intervals (CI). Subgroup analyses and sensitivity analyses were also conducted. Twenty-nine studies were identified for inclusion. Women with PCOS had higher risks of miscarriage (OR 1.41, 95% CI 1.04-1.91), ovarian hyperstimulation syndrome (OR 4.96, 95% CI 3.73-6.60), gestational diabetes mellitus (OR 2.67, 95% CI 1.43-4.98), pregnancy-induced hypertension (OR 2.06, 95% CI 1.45-2.91), preterm birth (OR 1.60, 95% CI 1.25-2.04) and large-for-gestational-age babies (OR 2.10, 95% CI 1.01-4.37). Women with PCOS showed similar rates of clinical pregnancy, multiple pregnancy, ectopic pregnancy, small for gestational age and congenital malformations, and a higher live birth rate, compared with women without PCOS. This study provides an update on and comprehensive evidence to support the observation that despite the fact that PCOS patients achieve a better live birth rate, physicians should continue to consider them to be at high risk of adverse pregnancy-related outcomes.
Copyright © 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IVF; Polycystic ovary syndrome; Pregnancy complications; Pregnancy outcomes

Year:  2019        PMID: 31255606     DOI: 10.1016/j.rbmo.2019.03.203

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  30 in total

Review 1.  Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome.

Authors:  Neil R Chappell; William E Gibbons; Chellakkan S Blesson
Journal:  Steroids       Date:  2022-02-18       Impact factor: 2.668

2.  Obstetric and Perinatal Complications Associated with Assisted Reproductive Techniques - Review.

Authors:  Andreea Madalina Banica; Simona Daniela Popescu; Simona Vladareanu
Journal:  Maedica (Bucur)       Date:  2021-09

Review 3.  Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis.

Authors:  Roberto Matorras; Jose Ignacio Pijoan; Lucía Laínz; María Díaz-Nuñez; Héctor Sainz; Silvia Pérez-Fernandez; Dayana Moreira
Journal:  Arch Gynecol Obstet       Date:  2022-09-04       Impact factor: 2.493

4.  Follicular fluid PlGF and IVF/ICSI outcomes among PCOS and normo-ovulatory women using different controlled hyperstimulation protocols: A prospective case-control study.

Authors:  Sally Kadoura; Marwan Alhalabi; Abdul Hakim Nattouf
Journal:  Ann Med Surg (Lond)       Date:  2022-06-25

5.  Association of Polycystic Ovary Syndrome Phenotypes With Adverse Pregnancy Outcomes After In-Vitro Fertilization/Intracytoplasmic Sperm Injection.

Authors:  Qiumin Wang; Honghong Wang; Ping Li; Xiufang Li; Ze Wang; Lei Yan; Yuhua Shi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

6.  Predictors of pregnancy after intrauterine insemination in women with polycystic ovary syndrome.

Authors:  Hui-Juan Guan; Lin-Qing Pan; Hang Song; Huai-Yun Tang; Li-Sha Tang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

7.  Live birth outcomes in infertile patients with class III and class IV obesity following fresh embryo transfer.

Authors:  Phillip A Romanski; Pietro Bortoletto; Brady Magaoay; Alice Chung; Zev Rosenwaks; Steven D Spandorfer
Journal:  J Assist Reprod Genet       Date:  2020-11-16       Impact factor: 3.412

8.  In vitro fertilisation (IVF) versus intracytoplasmic sperm injection (ICSI) in patients without severe male factor infertility: study protocol for the randomised, controlled, multicentre trial INVICSI.

Authors:  Sine Berntsen; Bugge Nøhr; Marie Louise Grøndahl; Morten Rønn Petersen; Lars Franch Andersen; Anne Lis Englund; Ulla Breth Knudsen; Lisbeth Prætorius; Anne Zedeler; Henriette Svarre Nielsen; Anja Pinborg; Nina La Cour Freiesleben
Journal:  BMJ Open       Date:  2021-06-24       Impact factor: 2.692

9.  Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses.

Authors:  Hui Ju Chih; Flavia T S Elias; Laura Gaudet; Maria P Velez
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-28       Impact factor: 3.007

10.  Association Between Pre-Pregnancy Body Mass Index and Miscarriage in an Assisted Reproductive Technology Population: A 10-Year Cohort Study.

Authors:  Pengfei Qu; Mingxin Yan; Doudou Zhao; Dongyang Wang; Shaonong Dang; Wenhao Shi; Juanzi Shi; Chunli Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.